Interleukin Genetics, Inc 

(Public, AMEX:ILI)   Watch this stock   
Find more results for ILI
Nov 12, 2009
Q3 2009 Conference Call
Nov 12, 2009
Q3 2009 Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -1049.33% -66.40%
Operating margin -1038.57% -66.42%
EBITD margin - -50.12%
Return on average assets -109.07% -46.60%
Return on average equity -3077.28% -90.69%
Employees 27 -

Address

135 Beaver Street
Waltham, MA 02452
United States - Map
+1-781-3980700 (Phone)
+1-781-3980720 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Interleukin Genetics, Inc discussions

  View all discussions »

Description

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the personalized health market. The Company has two segments: Personalized Health, which conducts, researches, develops, markets and sells genetic test panels primarily in inflammatory and metabolic areas, and Consumer Products, which comprises the Alan James Group (AJG) business focused on developing, selling and marketing nutritional supplements and products into retail consumer channels. The Company's development programs focus on osteoporosis and weight management genetic risk assessment tests. The Company’s genetic test development efforts are focused on programs, such as Weight Management Genetic Test, Obesity Management Genetic Test, Osteoarthritis Genetic Test, Osteoporosis Genetic Test, IL-1 Cardiovascular Genetic Test and Periodontal Disease Genetic Test (version 2.0).

Officers and directors

James M. Weaver
Chairman of the Board
Age: 44
Bio & Compensation - Reuters
Lewis H. Bender
Chief Executive Officer, Director
Age: 50
Bio & Compensation - Reuters
Eliot M. Lurier
Chief Financial Officer, Treasurer
Age: 50
Bio & Compensation - Reuters
Kenneth S. Kornman Ph.D.
President, Chief Scientific Officer, Director
Age: 61
Bio & Compensation - Reuters
George D. Calvert Ph.D.
Director
Age: 44
Bio & Compensation - Reuters
Thomas R. Curran Jr.
Director
Age: 50
Bio & Compensation - Reuters
Mary E. Chowning
Director
Age: 47
Bio & Compensation - Reuters
Glenn S. Armstrong Ph.D.
Director
Age: 58
Bio & Compensation - Reuters